Sensitivity to oxidative stress in DJ-1-deficient dopamine neurons: An ES-derived cell model of primary Parkinsonism

被引:211
作者
Martinat, C
Shendelman, S
Jonason, A
Leete, T
Beal, MF
Yang, LC
Floss, T
Abeliovich, A [1 ]
机构
[1] Columbia Univ, Dept Pathol, Ctr Neurobiol & Behav, New York, NY 10027 USA
[2] Columbia Univ, Dept Neurol, Ctr Neurobiol & Behav, New York, NY USA
[3] Columbia Univ, Taub Inst, New York, NY USA
[4] Cornell Univ, Weill Med Coll, Dept Neurol & Neurosci, New York, NY USA
[5] GSF Natl Res Ctr Environm & Hlth, Inst Dev Genet, Neuherberg, Germany
关键词
D O I
10.1371/journal.pbio.0020327
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The hallmark of Parkinson's disease (PD) is the selective loss of dopamine neurons in the ventral midbrain. Although the cause of neurodegeneration in PD is unknown, a Mendelian inheritance pattern is observed in rare cases, indicating a genetic factor. Furthermore, pathological analyses of PD substantia nigra have correlated cellular oxidative stress and altered proteasomal function with PD. Homozygous mutations in DJ-1 were recently described in two families with autosomal recessive Parkinsonism, one of which is a large deletion that is likely to lead to loss of function. Here we show that embryonic stem cells deficient in DJ-1 display increased sensitivity to oxidative stress and proteasomal inhibition. The accumulation of reactive oxygen species in toxin-treated DJ-1-deficient cells initially appears normal, but these cells are unable to cope with the consequent damage that ultimately leads to apoptotic death. Furthermore, we find that dopamine neurons derived from in vitro-differentiated DJ-1-deficient embryonic stem cells display decreased survival and increased sensitivity to oxidative stress. These data are consistent with a protective role for DJ-1, and demonstrate the utility of genetically modified embryonic stem cell-derived neurons as cellular models of neuronal disorders.
引用
收藏
页码:1754 / 1763
页数:10
相关论文
共 42 条
  • [11] Neuronal α-synucleinopathy with severe movement disorder in mice expressing A53T human α-synuclein
    Giasson, BI
    Duda, JE
    Quinn, SM
    Zhang, B
    Trojanowski, JQ
    Lee, VMY
    [J]. NEURON, 2002, 34 (04) : 521 - 533
  • [12] Characterization of the necrotic cleavage of poly(ADP-ribose) polymerase (PARP-1): implication of lysosomal proteases
    Gobeil, S
    Boucher, CC
    Nadeau, D
    Poirier, GG
    [J]. CELL DEATH AND DIFFERENTIATION, 2001, 8 (06) : 588 - 594
  • [13] Parkin-deficient mice exhibit nigrostriatal deficits but not loss of dopaminergic neurons
    Goldberg, MS
    Fleming, SM
    Palacino, JJ
    Cepeda, C
    Lam, HA
    Bhatnagar, A
    Meloni, EG
    Wu, NP
    Ackerson, LC
    Klapstein, GJ
    Gajendiran, M
    Roth, BL
    Chesselet, MF
    Maidment, NT
    Levine, MS
    Shen, J
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (44) : 43628 - 43635
  • [14] Is there a cause-and-effect relationship between α-synuclein fibrillization and Parkinson's disease?
    Goldberg, MS
    Lansbury, PT
    [J]. NATURE CELL BIOLOGY, 2000, 2 (07) : E115 - E119
  • [15] Early-onset Parkinson's disease caused by a compound heterozygous DJ-1 mutation
    Hague, S
    Rogaeva, E
    Hernandez, D
    Gulick, C
    Singleton, A
    Hanson, M
    Johnson, J
    Weiser, R
    Gallardo, M
    Ravina, B
    Gwinn-Hardy, K
    Crawley, A
    St George-Hyslop, PH
    Lang, AE
    Heutink, P
    Bonifati, V
    Hardy, J
    Singleton, A
    [J]. ANNALS OF NEUROLOGY, 2003, 54 (02) : 271 - 274
  • [16] Han BS, 2003, J NEUROSCI, V23, P5069
  • [17] Hattori N, 2000, NEUROPATHOLOGY, V20, pS85
  • [18] Parkin gene inactivation alters behaviour and dopamine neurotransmission in the mouse
    Itier, JM
    Ibáñez, P
    Mena, MA
    Abbas, N
    Cohen-Salmon, C
    Bohme, GA
    Laville, M
    Pratt, J
    Corti, O
    Pradier, L
    Ret, G
    Joubert, C
    Periquet, M
    Araujo, F
    Negroni, J
    Casarejos, MJ
    Canals, S
    Solano, R
    Serrano, A
    Gallego, E
    Sánchez, M
    Denèfle, P
    Benavides, J
    Tremp, G
    Rooney, TA
    Brice, A
    de Yébenes, JG
    [J]. HUMAN MOLECULAR GENETICS, 2003, 12 (18) : 2277 - 2291
  • [19] Oxidative stress in Parkinson's disease
    Jenner, P
    [J]. ANNALS OF NEUROLOGY, 2003, 53 : S26 - S36
  • [20] Understanding cell death in Parkinson's disease
    Jenner, P
    Olanow, CW
    [J]. ANNALS OF NEUROLOGY, 1998, 44 (03) : S72 - S84